Monograph
J05AF08 - Adefovir Dipivoxil |
Propably not porphyrinogenic |
PNP |
Rationale
Probably no significant CYP-interactions.
Chemical description
Oral prodrug to adefovir that is an acyclic nucleotide phosphonate analogue, which intracellularly is converted to adefovir diphosphate, inibitor of viral polymerases. Used, tabl 10 mg/d, in the treatment of chronic hepatitis B in adults with signs of liver engagement. The risk for CYP related drug interactions is considered low.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Hepsera 
Hepsera 
Hepsera
© NAPOS 2025